TELA News and Press, TELA Bio Inc. From 05/31/22

MALVERN, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the p...

MALVERN, Pa., May 26, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s...

The following slide deck was published by TELA Bio, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: TELA Bio, Inc. 2022 Q1 - Results - Earnings Call Presentation

Image source: The Motley Fool. TELA Bio, Inc. (NASDAQ: TELA) Q1 2022 Earnings Call May 10, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: TELA Bio, Inc. (TELA) Q1 2022 Earnings Call Transcript

TELA Bio press release (NASDAQ:TELA): Q1 GAAP EPS of -$0.75 misses by $0.14. Revenue of $8.23M (+39.5% Y/Y) beats by $0.28M. For further details see: TELA Bio GAAP EPS of -$0.75 misses by $0.14, revenue of $8.23M beats by $0.28M

MALVERN, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own an...

MALVERN, Pa., May 09, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s...

MALVERN, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own ...

MALVERN, Pa., March 30, 2022 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’...

TELA Bio, Inc. (TELA) Q4 2021 Earnings Conference Call March 21, 2022 16:30 ET Company Participants Louisa Smith - Investor Relations Tony Koblish - President and Chief Executive Officer Roberto Cuca - Chief Operating Officer and Chief Financial Officer Conference Call Participants Drew Staff...